7Baggers

Kaleyra . Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Stock-Based Compensation  
 Operating Cash Flow  
 Investing Cash Flow  
 Financing Cash Flow  
 Free Cash Flow  
 Capital Expenditure  
20181231 20190331 20190630 20190930 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 -13.65-9.36-5.06-0.763.547.8412.1416.44Milllion

Kaleyra . Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
                    
  cash flows from operating activities:                  
  net income-9,089,000 -9,964,000 -57,845,000 -11,674,000 -15,837,000 -13,172,000 -7,293,000 -11,859,000 -4,487,000 -10,358,000 -4,526,000 -5,333,000 -8,128,000 -8,823,000 -560,733 -114,030 -247,272 -164,103 
  adjustments to reconcile net income to net cash from operating activities:                  
  depreciation and amortization4,513,000 4,435,000 5,952,000 5,719,000 5,936,000 5,902,000 6,028,000 5,516,000 2,551,000 909,000 866,000 638,000 631,000 638,000     
  stock-based compensation1,973,000 2,013,000 1,464,000 4,457,000 8,490,000 6,759,000             
  write off of property and equipment                  
  impairment of intangible assets                  
  non-cash reduction to the right-of-use asset-14,000 10,000                 
  benefit from doubtful accounts1,660,000 2,503,000 901,000 495,000 749,000 176,000  -16,000 -5,000 813,000         
  realized gains on marketable securities8,000 8,000 7,000 6,000 4,000 5,000 13,000 -4,000 23,000 -2,000         
  employee benefit obligation182,000 144,000 -385,000 134,000 238,000 514,000 293,000 122,000 53,000 69,000 151,000 123,000 164,000 89,000     
  change in fair value of warrant liability14,000 12,000 -14,000 -39,000 -276,000 -534,000 -118,000 -166,000 -433,000 1,263,000         
  non-cash interest expense562,000 528,000 551,000 483,000 524,000 490,000 509,000 420,000 210,000 115,000 40,000 34,000 45,000 72,000     
  deferred taxes  -5,589,000 524,000 -644,000 820,000 -1,180,000 -68,000 -7,467,000 663,000 -1,849,000 -262,000 -313,000 -323,000     
  change in operating assets and liabilities:                  
  trade receivables7,658,000 481,000 28,000 7,374,000 -16,329,000 3,010,000 -4,144,000 -5,476,000 -7,699,000 440,000 -1,399,000 128,000 -917,000 1,710,000     
  other current assets-488,000 -275,000 -1,790,000 170,000 412,000 1,504,000 287,000 -324,000 -2,195,000 -164,000 -687,000 -54,000 827,000 1,111,000     
  deferred cost-20,000 -15,000 28,000 -18,000 -10,000 22,000             
  operating lease liability-1,000 3,000                 
  other long-term assets-222,000 -542,000 287,000 -264,000 -113,000 -1,074,000 -5,000 -62,000 -16,000 1,499,000 -10,000 -39,000 360,000 -808,000     
  accounts payable-7,328,000 -2,614,000 3,199,000 6,316,000 6,177,000 -816,000 -2,889,000 6,679,000 2,246,000 -4,128,000 1,895,000 -8,352,000 319,000 -5,694,000 116,262 54,923 -20,833 1,176,790 
  other current liabilities-4,316,000 6,399,000 -2,477,000 4,217,000 -656,000 2,334,000 722,000 3,921,000 227,000 -2,735,000 3,429,000 -1,596,000 1,533,000 3,526,000 -115,949 -28,740 17,219 -7,326 
  deferred revenue-848,000 -276,000 -1,957,000 -1,429,000 319,000 -2,708,000 -1,442,000 131,000 7,394,000 -474,000 2,067,000 -19,000 -35,000 206,000     
  long-term liabilities137,000 -397,000 370,000 -33,000 -47,000 -40,000 -49,000 521,000 -64,000 -18,000 -1,314,000 117,000 -807,000 1,505,000     
  net cash from operating activities-5,078,000 2,453,000 -7,877,000 16,438,000 -11,063,000 3,192,000 -4,015,000 5,196,000 -4,906,000 -8,207,000 1,692,000 -9,593,000 -1,569,000 -2,852,000 -338,937 -516,459 -602,542 -495,083 
  capex-2,150,000 -2,037,000 -1,923,000 -2,854,000 -2,592,000 -2,876,000 -3,093,000 -2,180,000 -951,000 -859,000 -378,000 -1,178,000 -1,045,000 -820,000 
  free cash flows-7,228,000 416,000 -9,800,000 13,584,000 -13,655,000 316,000 -7,108,000 3,016,000 -5,857,000 -9,066,000 1,314,000 -10,771,000 -2,614,000 -3,672,000 -338,937 -516,459 -602,542 -495,083 
  cash flows from investing activities:                  
  purchase of short-term investments-46,000 -1,165,000 -50,342,000   4,000 -2,997,000 -1,741,000 -3,179,000     
  sale of short-term investments  26,000 36,000   30,195,000 20,000,000 546,000 341,000 2,774,000 5,041,000     
  purchase of property and equipment-657,000 -231,000 -343,000 -792,000 -422,000 -544,000 -1,015,000 -665,000 -86,000 -91,000 555,000 -475,000 -405,000 -89,000     
  capitalized software development costs-1,493,000 -1,806,000 -1,580,000 -2,062,000 -2,170,000 -2,332,000 -2,078,000 -1,515,000 -865,000 -768,000 -933,000 -703,000 -640,000 -731,000     
  purchase of intangible assets    -7,000 -21,000 -1,000 -2,000 -6,000     
  acquisition of bandyer, net of cash acquired  -1,063,000 58,000            
  net cash from investing activities-2,142,000 -2,083,000 -1,897,000 -2,818,000 2,787,000 -3,983,000 27,095,000 -45,484,000 -198,543,000 -315,000 -33,000 -1,401,000 -2,786,000 1,052,000 -496,928 70,252,117 -1,021,911 222,115 
  cash flows from financing activities:                  
  proceeds from (repayments on) line of credit475,000 -1,014,000 380,000 279,000    237,000           
  repayments on term loans-3,052,000 -3,340,000 -2,286,000 -2,391,000 -2,359,000 -2,134,000 -2,854,000 -1,423,000 -1,582,000 -1,869,000 -2,307,000 -603,000 -278,000 -5,463,000     
  repayments on notes      -3,750,000 -3,750,000         
  repayments on capital lease-50,000 -48,000 -183,000 -13,000 -17,000 -29,000 -35,000 -37,000 -29,000 -37,000         
  net cash from financing activities-3,032,000 -4,402,000 -2,089,000 394,000 -3,627,000 -2,688,000 -3,001,000 -5,429,000 286,065,000 11,970,000 -1,906,000 4,857,000 4,472,000 2,304,000 976,327 -69,543,760   
  effect of exchange rate changes on cash, cash equivalents and restricted cash-244,000 902,000  -1,129,000 -1,896,000 -334,000  -867,000 502,000 -911,000  403,000 84,000 -454,000     
  net decrease in cash, cash equivalents and restricted cash-10,496,000 -3,130,000                 
  cash, cash equivalents and restricted cash, beginning of period77,980,000 91,702,000   32,970,000 36,997,000     
  cash, cash equivalents and restricted cash, end of period-10,496,000 74,850,000 -8,995,000 12,885,000 -13,799,000 87,889,000   83,118,000 35,507,000 1,456,000 -5,734,000 201,000 37,047,000     
  supplemental disclosures of cash flow information:                  
  cash paid for interest6,428,000 351,000   6,287,000 173,000    368,000 221,000 289,000 295,000 153,000     
  cash paid for income taxes                  
  non-cash investing and financing activities                  
  restricted stock units granted to employees for bonuses                  
  consideration payable488,000                 
  adoption of asc 326-1,270,000                 
  reversal of accrued interest on forward share purchase agreement      -659,000         
  acquisition of mgage, net of cash acquired      363,000           
  borrowings on term loans        -1,000 15,637,000 8,800,000     
  proceeds from issuance of convertible notes, net of issuance costs                
  receipts related to forward share purchase agreements                  
  proceeds from issuance of common stock in private investment in public equity offering (pipe), net of issuance costs                 
  proceeds related to settlement of non-forfeited 2020 sponsor earnout shares      1,244,000         
  proceeds from exercise of common stock warrants                  
  repurchase of warrants                 
  effect of exchange rate changes on cash, cash equivalent and restricted cash                  
  net increase in cash, cash equivalents and restricted cash  -8,995,000 12,885,000 -13,799,000 -3,813,000   83,118,000 2,537,000 1,456,000 -5,734,000 201,000 50,000     
  supplemental disclosure of cash flow information:                  
  non-cash investing and financing activities:                  
  change in value of forward share purchase agreements         -483,000 3,000 -1,942,000 271,000     
  common stock issued to vivial equity holders                  
  stock-based compensation related to capitalized software development costs                  
  conversion of convertible note to common stock                  
  fair value of warrant liability                  
  asset acquired under capital leases                  
  initial recognition of the lease at commencement                  
  proceeds from issuance of common stock in private investment in public equity offering, net of issuance costs                  
  proceeds from the exercise of common stock warrants                 
  repayments on line of credit     -525,000             
  stock-based compensation capitalized as software development costs                  
  receivable for proceeds from the exercise of warrants                  
  stock-based compensation, preference shares and others      4,901,000 5,820,000 4,710,000 4,560,000         
  non-cash settlement of preference share liability          -2,486,000     
  benefit from (recovery of) doubtful accounts                  
  sale of property and equipment          16,000     
  proceeds from line of credit                  
  repurchase of common stock in connection with forward share purchase agreements          -6,213,000 -21,631,000 -2,587,000     
  receipts (payments) related to forward share purchase agreements      17,045,000         
  proceeds from issuance of stock in public offering, net of issuance costs          3,472,000       
  common stock issued to settle payables                  
  note payable issued to settle payables                  
  deferred costs       41,000           
  proceeds from issuance of common stock in public offering, net of issuance costs                  
  proceeds from (repayments on) in line of credit         -663,000         
  common stock issued to settle a payable           2,700,000 423,000     
  note payable issued to settle a payable           2,700,000 400,000     
  cash, cash equivalents and restricted cash acquired in the reverse merger                  
  payments of deferred consideration for the acquisition of buc mobile                  
  payments of deferred consideration for the acquisition of solutions infini                  
  change in line of credit          528,000 -604,000 -368,000 1,721,000     
  payments related to forward share purchase agreements          -832,000 -453,000 -167,000     
  stock-based compensation, preference share and unpaid bonuses           4,922,000       
  allowance for doubtful accounts           100,000 -73,000 117,000     
  payment of deferred consideration for the acquisition of buc mobile                  
  payment of deferred consideration for the acquisition of solutions infini                  
  repayments on notes payable           -6,000,000       
  non-cash financing activities:                  
  issuance costs for public offering included in accounts payable                  
  stock-based compensation and preference share liability             6,308,000     
  stock-based compensation and preference shares                  
  loss on equity investments                  
  purchases of marketable securities                  
  sales of marketable securities                  
  purchases of property and equipment                  
  sales of property and equipment                  
  purchases of intangible assets                  
  acquisition of buc mobile, net of cash acquired                  
  acquisition of solutions infini, net of cash acquired                  
  payment of deferred consideration in relation to the acquisition of buc mobile                  
  payment of deferred consideration in relation to the acquisition of solutions infini                  
  borrowings on term loan                  
  repayments on term loan                  
  proceeds from exercise of stock options                  
  cash, cash equivalents and restricted cash at beginning of year                  
  cash, cash equivalents and restricted cash at end of year                  
  supplemental disclosures of other cash flow information:                  
  operating activities                  
  interest earned on cash and marketable securities held in trust account              -422,455 -612,480 -786,533 -706,074 
  interest receivable on cash and marketable securities held in trust account              35,038 -96,095 -18,359 -41,112 
  receivable from related party              -6,946 4,063 2,166 
  prepaid expenses              20,520 13,854 47,187 17,416 
  payable to related party              79,302 24,197   
  accrued liabilities              509,078 248,858 382,064 -772,840 
  investing activities                  
  investment of cash in trust account              -720,000 -240,000   
  interest income used to pay taxes              223,072    
  cash withdrawn from trust account              69,542,655 415,589 222,115 
  financing activities                  
  proceeds from sale of units, net of underwriting discounts paid                  
  proceeds from sale of private placement units                  
  proceeds from the sale of founder shares                  
  redemption of public shares                  
  notes payable to founders                  
  repayment of notes payable to founders                  
  payment of deferred offering costs                  
  net change in cash and cash equivalents              140,462 191,898 -186,953 -272,968 
  cash and cash equivalents, beginning of period              597,268 
  cash and cash equivalents, end of period              140,462 191,898 -186,953 324,300 
  supplemental disclosure of noncash investing activities                  
  change in value of common stock subject to possible redemption              -1,611,550 936,780 -247,272 -164,103 
  proceeds from sale of private placement shares                  
  promissory notes from related parties                  
  repayment of promissory notes from related parties                  
  redemption of common stock                  
  promissory notes issued in conjunction with extension                  
  promissory notes for extension                  
  restricted cash                  
  interest earned on marketable securities held in trust account                  

We provide you with 20 years of cash flow statements for Kaleyra . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kaleyra . stock. Explore the full financial landscape of Kaleyra . stock with our expertly curated income statements.

The information provided in this report about Kaleyra . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.